Introduction:

sarcopenia and frailty are mutual risk clinical syndromes and adverse outcome indicators. There are currently no data in Latin America regarding the prevalence of these conditions in hospitalized patients.

Objective:

to determine the prevalence and clinical characteristics of patients age 65 and older with sarcopenia in internal medicine wards.

Materials and methods:

an observational, descriptive, prospective cross-sectional study, including men and women age 65 and older. The EWGSOP (European Working Group on Sarcopenia in Older People) and PRISMA 7 criteria were applied to determine sarcopenia and frailty, respectively.

Results:

out of 124 patients, 41.13% had sarcopenia, 34.68% had frailty and 18.55% had both. The median age was 74; 50.8% were women and 49.2% men.

Conclusion:

sarcopenia and frailty are highly prevalent in our population, with higher figures than those reported in the available literature. Subsequent studies may determine the effect of these conditions on clinical outcomes and costs. (Acta Med Colomb 2020; 45. DOI:https://doi.org/10.36104/amc.2020.1242)

        · resumo em Espanhol     · texto em Inglês | Espanhol     · Inglês ( pdf ) | Espanhol ( pdf )